MedscapeLIVE! Newsletter

Greetings, Psychiatry Newsletter Readers! This spring and summer, we are sitting down with a handful of key opinion leaders in psychiatric care for a series called Candid Dish, where we ask them what their real thoughts are on many potential up-and-coming novel treatments.

—

May

Medscape is excited to bring you another issue of the Psychiatry E-newsletter! We have a lot of programs/events in the pipeline. Keep reading to learn about the upcoming resident program at Psychiatry Update, as well as other information for the upcoming Psychiatry Update and Psychopharmacology Update conferences. Spots are limited for the Psychiatry Update resident program, the Early Career Provider Program. Act quickly and share this email with a colleague who may be interested so they can secure a spot. We hope to see you at one of our upcoming events in 2024!

—

March

Welcome back to the Psychiatry newsletter! With 2024 off and running, we are all busy with our practices and personal lives. Finding the balance between them can be challenging, especially when so much is going on in psychiatry research and development and we try to keep up. Medscape has some exciting learning events and opportunities to help you via upcoming meetings, target interviews, and more. We will help you get up to speed on the rapidly expanding realm of research in psychiatry.

—

October

Welcome back, Innovations Readers! Last month Dr. Henry A. Nasrallah, Chair of the 22nd Annual Psychopharmacology Update, shared that there is “a surge of new innovative medications based on novel mechanisms of action to be discussed,” and went on to list them. For this month, we decided to run that list by our foremost thought leaders in psychiatry and addiction medicine who are faculty at the upcoming Psychopharmacology Update. and get their immediate thoughts.

—

September

We are back this month with our special segment “5 Minutes With” that focuses on our faculty for the upcoming Psychopharmacology Update. They share strategic pearls from their upcoming presentations, what they think are some of the latest breakthroughs in psychopharmacology that attendees can look forward to learning more about, and what attendees will come away with that will greatly improve their treatment armamentarium. Read on for candid insights on these topics and more.

—

August

We’re back this month with Dr. Henry A. Nasrallah, Chair of the upcoming 22nd Annual Psychopharmacology Update. Dr. Nasrallah is the Editor-in-Chief of Current Psychiatry; and Vice-Chair for Faculty Development and Mentorship and Professor of Psychiatry, Neurology, & Neuroscience; Director, Neuropsychiatry and Schizophrenia Programs at the University of Cincinnati College of Medicine. Dr. Nasrallah is a well-respected researcher and has published in multiple therapeutic areas. As Editor of Current Psychiatry, he also brings an informed perspective to where we are in research and treatment options for psychiatric conditions.

—

July

Happy July! This month we feature some of our foremost thought leaders in psychiatry and faculty for Psychiatry Update Spring 2023 sharing their most memorable cases. Our last issue featured Part 2 “5 Minutes With” with Dr. Christoph Correll, Dr. Margaret Sibley, Dr. Ann Childress, Dr. Holly Swartz, and Dr. Donald Black. Topics included the best tool in their clinical arsenals, mental health therapies that are safe and easy to incorporate but may be underutilized, and specific advances on the horizon that will greatly improve their treatment armamentarium. If you missed it, you can find that interview here.

—

June

Happy June, Innovations Readers! We are back with the second part of our special segment “5 Minutes With” that questions some of our foremost thought leaders in psychiatry who also served as faculty for Psychiatry Update Spring 2023 in Chicago. They opine on the best tool in their clinical arsenals, mental health therapies that are safe and easy to incorporate but may be underutilized, and specific advances on the horizon that will greatly improve their treatment armamentarium. Read on for candid insights from Dr. Christoph Correll, Dr. Margaret Sibley, Dr. Ann Childress, Dr. Holly Swartz, and Dr. Donald Black.

—

May

Happy Spring, Innovations Readers! We are back this month with Dr. Marlene Freeman, who serves this year as the new co-chair for the upcoming June Psychiatry Update Spring 2023 meeting in Chicago. In this issue, we discuss the upcoming meeting, new treatments for mood disorders to be covered in her Session VII: Moving Forward in Mood Disorders, her role as Editor in Chief of The Journal of Clinical Psychiatry and the great need to bring the evidence base to clinical care, what she has learned serving as Medical Director of the Clinical Trials Network and Institute (CTNI) at Massachusetts General Hospital and her unique perspective on advancing research, and her upcoming Psych Update Spring talk, Updates in Postpartum Depression and Anxiety.

—

April

We are back with a special segment called “5 Minutes With” that questions some of our foremost thought leaders in psychiatry. These key opinion leaders also happen to serve as faculty for the upcoming June Psychiatry Update Spring 2023 in Chicago.

—

March

We are back again this month with some of our thought leaders in psychiatry talking shop in a rapid-fire format— this month touching on the most promising new treatment, preference on meeting/conference—live or virtual, and best recent publication. Read on for candid insights from Dr. Christoph Correll, Dr. Margaret Sibley, Dr. Ann Childers, Dr. Holly Swartz, and Dr. Donald Black.

—

February

This month our Rapid Fire covers hot topics with trailblazers in the field of psychiatry—highlighting the most significant advances and treatments of 2022, major challenges of the past year, what they look forward to in 2023, and the level of patient severity—has it increased? Read on for some tidbits and insights from these thought leaders, including Dr. Christoph Correll, Dr. Margaret Sibley, Dr. Ann Childers, Dr. Holly Swartz, and Dr. Donald Black. Part 2 next month will focus on the most promising new treatment, preference on meeting/conference—live or virtual, and best recent publication!

—

January

Happy New Year! This month we speak with Dr. Sagar Parikh, the John F. Greden Professor of Depression and Clinical Neuroscience at the University of Michigan as well as Medical Director of the National Network of Depression Centers. Dr. Parikh is a former primary care physician and long-time psychiatrist with extensive clinical and research experience across the US and Canada. We discuss the land mines to avoid in applying genetic tests in the context of antidepressant choice, pearls regarding the mental health crisis on college campuses, current key evidence on use of pharmacogenomic results to help tailor medication strategies, a recent publication he found to be critical in his own practice, and his thoughts on where we will be with pharmacogenomic treatment options in 10 years.

Psychiatry Newsletters

Candid Dish on Treatments—Round 1!

MedscapeLIVE! Psychiatry E-News May 2024

MedscapeLIVE! Psychiatry 2024

October Psychiatry E-News The Dish on New Treatments!

5 Minutes With… Psychopharmacology Update Faculty

Catching up With Dr. Henry A. Nasrallah, Psych Update Spring 2023 Co-Chair

Most Memorable Cases with Psych Update Spring 2023 Faculty

5 Minutes With… Psych Update Spring 2023 Faculty Pt.2

Catching up With Dr. Marlene Freeman, Psych Update Spring 2023 Co-Chair

5 Minutes With… Psych Update Spring 2023 Faculty

Rapid Fire Part 2: Heart to Heart with Psychiatry Trailblazers

Rapid Fire Part 1: Heart to Heart with Psychiatry Trailblazers

Catching Up with Dr. Sagar Parikh: Pharmacogenomics, College and Mental Health, and Much More!